| 1 |
LU2026682919 |
Candriam Equities L Biotechnology, V2 - Capitalisation |
-7,82 % |
+21,55 % |
-0,46 |
| 2 |
LU1540961759 |
HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund A Cap USD |
-6,96 % |
+19,29 % |
-0,47 |
| 3 |
LU0942225912 |
Candriam Equities L Biotechnology, R - Capitalisation |
-8,03 % |
+21,53 % |
-0,47 |
| 4 |
LU1540962054 |
HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund P Cap USD |
-7,44 % |
+20,10 % |
-0,48 |
| 5 |
LU0317020203 |
Candriam Equities L Biotechnology, V - Capitalisation |
-8,37 % |
+21,37 % |
-0,49 |
|
|
| 51 |
LU0400035332 |
UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse Q-acc, USD |
-14,16 % |
+22,42 % |
-0,73 |
|
|
| 80 |
LU0415392678 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I EUR - Accumulating |
-14,71 % |
+13,87 % |
-1,22 |
| 81 |
LU0415392249 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B EUR - Accumulating |
-15,30 % |
+13,87 % |
-1,26 |
| 82 |
LU0415392835 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating |
-18,72 % |
+14,65 % |
-1,42 |
| 83 |
LU0767968745 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I GBP - Accumulating |
-16,30 % |
+12,92 % |
-1,43 |
| 84 |
LU0415392595 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating |
-19,28 % |
+14,65 % |
-1,46 |